Researchers find new medicine which can stimulate food intake for esophageal cancer patients during chemotherapy. Doctors at Osaka University in Japan administrated the synthetic “ghrelin” to 42 patients with esophageal cancer through an intravenous infusion for one week.
Researchers cound that the patients who were administered the ghrelin, had higher food intake and appetite versus those in a placebo controlled group. Those in the ghrelin group also experienced less nausea.
Researchers stated, “we believe that ghrelin administration could increase the efficiency of chemotherapy, and we recommend the use of ghrelin in clinical practice.”
To read more about this revolutionary new medicine, click here.